Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets

Approval Number

国药准字H20243634

Company北京北陆药业股份有限公司

Registration Date

April 30, 2024

Drug Information

Generic Name

盐酸帕罗西汀肠溶缓释片

Dosage Form

片剂

Strength

25mg（按C₁₉H₂₀FNO₃计）

Drug Type

化学药品

Registration Date

April 30, 2024

Company Information

Applicant Company

Company Name北京北陆药业股份有限公司

Company Address

北京市密云区水源西路3号

Manufacturing Company

Company Name广州玻思韬控释药业有限公司

Company Address

广州市黄埔区瑞祥路228号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸帕罗西汀肠溶缓释片 - NMPA 批准文号 | MedPath